Drug Trial Radar · NCT05087134
Characterizing LAM With 11C-Choline PET/CT
Last checked: Nov 20, 2026Latest source record: Oct 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 2021
Primary completion
Sep 2022
Study completion Sep 2023
Sponsor
- Lead sponsor
- Peking Union Medical College HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 21, 2021
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
It was reported that TSC2-deficient cells enhance phosphatidylcholine synthesis via the Kennedy pathway. 11C-Choline can reflect the metabolic process of choline in vivo by intravenous injection. The purpose of this study is the ability of 11C-Choline PET/CT to evaluate the baseline condition of LAM patients and the efficacy of rapamycin after treatment.
Conditions
- Lymphangioleiomyomatosis
Interventions
11C-CholineDrug
11C-Choline were injected into the patients before the PET/CT scans
Primary outcomes
What the sponsor says the trial is designed to measure.
- Standardized uptake value of 11C-Choline in LAM lesionsTime frame: through study completion, an average of 2 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking union medical college hospital
Beijing, Dongcheng, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.